Meeder Asset Management Inc G1 Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$9.57 - $24.37 $985 - $2,510	-103 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$9.07 - $26.32 $798 - $2,316	-88 Reduced 46.07%	103 $1,000
Q4 2019 Feb 13, 2020	BUY	$20.54 - $31.0 $1,129 - $1,705	55 Added 40.44%	191 $5,000
Q3 2019 Oct 17, 2019	BUY	$22.78 - $40.58 $3,098 - $5,518	136 New	136 $3,000
Q1 2019 Apr 16, 2019	SELL	$14.4 - $21.45 $64,569 - $96,181	-4,484 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$16.51 - $51.33 $44,147 - $137,256	2,674 Added 147.73%	4,484 $87,000
Q3 2018 Nov 02, 2018	BUY	$43.15 - $67.97 $992 - $1,563	23 Added 1.29%	1,810 $0
Q2 2018 Jul 24, 2018	BUY	$35.06 - $51.17 $62,652 - $91,440	1,787 New	1,787 $0

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.